The FDA has accepted a new drug application for the intravesical solution of UGN-102 in low-grade intermediate-risk ...

The patient was in his 60s, an African American man with emphysema. The oximeter placed on his fingertip registered well ...

This study investigates the use of Oxford Nanopore sequencing on circulating cell-free DNA (cfDNA) derived from blood plasma to detect key copy number alterations (CNAs) in lung cancer patients. CNAs ...

GEORGIA AVENUE, WA, UNITED STATES, October 17, 2024 /EINPresswire / -- The latest release from Vantage <a target=_blank href= ...

Electronic nudges had a small impact on flu vaccine uptake in patients without diabetes but showed no significant effect ...

This technology quickly and sensitively detects metabolites and changes in cancer patients' body fluids, providing a non-invasive way to diagnose cancer instead of traditional blood draws or biopsies.

Know Labs, Inc. , a leading developer of non-invasive sensor technology, announced today that it has retained The Stanbridge Group to secure a strategic relationship with an automotive original ...

This study presents a noninvasive biosensor that measures glucose levels through sweat, providing an alternative to ...

Some say our eyes are a window to the soul and one tech company is taking that notion further with next-generation contact ...

Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...

It is a more direct measure of adiposity, which strongly correlates with metabolic diseases like type 2 diabetes. In a large ...